CTRI/2019/05/018883
Recruiting
未知
Serum Transthyretin as predictor to outcome in critically ill trauma patients
institute of medical sciences BH0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: T07- Unspecified multiple injuries
- Sponsor
- institute of medical sciences BH
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Critically ill Trauma patients
Exclusion Criteria
- •1\.Not consenting
- •2\. pregnancy
- •3\. Hemodynamically unstable patients
- •4\. Associated liver diseases
- •5\. Heart diseases
- •6\. Renal diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M TransthyretiTransthyretin Familial Amyloid PolyneuropathyJPRN-jRCT2080221636Pfizer Japan Inc.10
Not yet recruiting
Not Applicable
To check for the levels of proteins specific to skin color and thyroid hormone levels in a condition of white patches over skin called vitiligo and finding their relation with the severity of diseaseCTRI/2022/09/046017Father Muller Medical College
Completed
Not Applicable
Troponin- I Elevation Predicts Outcome After Thrombolysis in Stroke PatientsCerebrovascular AccidentNCT03925298Zagazig University81
Completed
Not Applicable
Clinical study of tolcapone for transthyretin (TTR)-type cerebral amyloid angiopathy in patients with familial amyloid polyneuropahty (FAP)Familial amyloid polyneuropahtyJPRN-UMIN000030341Shinshu University School of Medicine9
Recruiting
Not Applicable
Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral HemorrhageIntracerebral HemorrhageLow T3 SyndromeNeurocritical CareHormone Replacement TherapyNCT06353555Peking Union Medical College Hospital100